MKI67 and breast carcinoma: In regard to whether Ki-67 (protein expressed in the nucleus of cells during different phases of the cell cycle; principally used to evaluate prognosis) is required to define low-risk breast cancer, 56% (28/50) thought Ki-67 would improve their confidence in identifying low-risk breast cancer but that it was not absolutely necessary.